Octavio Espinoza is Chief Financial Officer of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 27,932 shares of LGND, which is worth approximately $2.91 Million. The most recent transaction as insider was on Dec 30, 2022, when has been sold 275 shares (Common Stock) at a price of $56.78 per share, resulting in proceeds of $15,614. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.9K
47.95% 3M change
19.47% 12M change
Total Value Held $2.91 Million

Octavio Espinoza Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 30 2022
BUY
Other acquisition or disposition
$15,614 $56.78 p/Share
275 Added 1.43%
18,945 Common Stock
Dec 13 2022
BUY
Grant, award, or other acquisition
-
11,000 Added 37.07%
18,670 Common Stock
Nov 30 2022
SELL
Payment of exercise price or tax liability
$86,532 $72.9 p/Share
1,187 Reduced 13.4%
7,670 Common Stock
Nov 09 2022
SELL
Open market or private sale
$128,285 $75.64 p/Share
1,696 Reduced 16.07%
8,857 Common Stock
OE

Octavio Espinoza

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Track Activities on LGND